CHARLOTTESVILLE, Va., March 13, 2019 /PRNewswire/ -- HemoSonics today announced that its innovative Quantra Hemostasis Analyzer platform, and its ...
Wednesday, 20 March 2019
FDA grants de novo for the HemoSonics' Quantra® QPlus System; This Revolutionary Diagnostic Provides Unique Information for Accessing Coagulation at the Point of Care; Now Commercially Available in US - PRNewswire
FDA grants de novo for the HemoSonics' Quantra® QPlus System; This Revolutionary Diagnostic Provides Unique Information for Accessing Coagulation at the Point of Care; Now Commercially Available in US PRNewswire
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment